Actively Recruiting
Effects of Protein and NAC Co-ingestion on Skeletal Muscle Recovery
Led by University of Thessaly · Updated on 2025-06-04
30
Participants Needed
1
Research Sites
68 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Previous evidence suggests that though N-acetylcysteine (NAC) supplementation following eccentric exercise-induced muscle damage disrupts the skeletal muscle's repair and remodelling process at 8 days of recovery, it attenuates substantially the decline of skeletal muscle performance during the first 48 hours of recovery. The enhanced performance capacity during the first phase of recovery in response to NAC supplementation might be attributed to the altered redox status in skeletal muscle as a consequence of the NAC-mediated elevation of reduced glutathione (GSH) levels. The rise in GSH results in a redox-dependent attenuation of immune cell mobilisation and reduction of oxidative stress response, leading to a blunted rise of muscle damage and inflammatory markers during the first 2-3 days of recovery. However, following exercise-induced muscle damage, protein synthesis increases in skeletal muscle over the next 24-48 hours to support its repair process, and thus protein supplementation might accelerate the recovery process by enhancing the protein synthetic response. Therefore, the present study aims at investigating for first time the combined effect of NAC and whey protein supplementation on the short-term (during the first 72 hours) recovery process of skeletal muscle following damaging exercise (eccentric exercise) and compared it with the well-documented efficacy of NAC supplementation. The results of this study might be particularly useful for athletes, such as those in soccer and basketball, that participate in 3 games or intense training sessions during the same macrocycle with only 48-72 hours of recovery in-between.
CONDITIONS
Official Title
Effects of Protein and NAC Co-ingestion on Skeletal Muscle Recovery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged 18 to 27 years
- Free of asthma, kidney disease, bleeding disorders, and peptic ulcers
- No musculoskeletal injuries or physical limitations
- Not following any dietary energy restrictions
- Not using anti-inflammatory drugs, antibiotics, antihypertensive drugs, or anticoagulants
- Not using dietary supplements such as protein, carbohydrate, antioxidants, or vitamins
- No intolerance to N-acetylcysteine
- Non-smokers
- Abstain from alcohol during the study
You will not qualify if you...
- Presence of asthma, kidney disease, bleeding disorders, or peptic ulcers
- Any musculoskeletal injuries or physical limitations
- Following dietary energy restriction
- Use of anti-inflammatory drugs, antibiotics, antihypertensive drugs, or anticoagulants
- Use of dietary supplements such as protein, carbohydrate, antioxidants, or vitamins
- Intolerance to N-acetylcysteine
- Smoking
- Alcohol consumption during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Physical Education and Sport Science, University of Thessaly
Trikala, Karies, Greece, 42100
Actively Recruiting
Research Team
D
Dimitrios Draganidis, PhD
CONTACT
I
Ioannis G Fatouros, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here